A nasal spray that contains esketamine — a potent derivative of ketamine — can now be taken on its own to treat adults with ...

The Food and Drug Administration recently expanded approval for Spravato, an antidepressant nasal spray used to treat ...

The FDA has accepted for review the NDA for bumetanide nasal spray for edema associated with CHF, as well as hepatic and renal disease.

People with treatment-resistant depression can now take Spravato's ketamine-derived nasal spray as a standalone treatment.

A ketamine-derived nasal spray is now available for the millions of Americans living with severe depression. The ...

Another natural method that may help you find relief from environmental factors behind your post-nasal drip is by inhaling ...

Mumbai: Global pharma major Lupin Limited has announced that it has received tentative approval from the United States Food ...

Public trust in a federal access program for the overdose drug Naloxone has been shaken after more than a year of shortages ...

People in Phoenix suffering from severe depression now have a Ketamine-derived nasal spray available for treatment.

In a Phase IIb trial, GH001 elicited significant drops in treatment-resistant depression. The news comes less than two weeks ...

But if you’re suffering from one of seven common health conditions, you can actually avoid GP waits altogether by going to ...